^
Association details:
Biomarker:No biomarker
Cancer:Small Lymphocytic Lymphoma
Drug:Gazyva (obinutuzumab) (CD20 inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Chronic lymphocytic leukemia/Small lymphocytic lymphoma…Other recommended regimens…Obinutuzumab
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Chronic lymphocytic leukemia/Small lymphocytic lymphoma: Useful in Certain Circumstances…Obinutuzumab ± chlorambucil...
Secondary therapy:
chlorambucil